Resilience in East Asian Immigrants for Advance Care Planning Discussions
Development of a Culturally Tailored Digital Resilience-Building Intervention for East Asian Immigrants With Cancer to Facilitate Advance Care Planning Discussions
University of Illinois at Chicago
84 participants
Oct 27, 2023
OBSERVATIONAL
Conditions
Summary
The purpose of the study is to develop a culturally tailored digital resilience-building intervention to help East Asian immigrants engage in advance care planning discussions with their family caregivers.
Eligibility
Inclusion Criteria11
- Age ≥ 18 years
- Serving as a chaplain or religious leader at a healthcare setting or religious organization
- Having experience providing pastoral or spiritual care to Chinese, Japanese, and Korean Americans in the US
- Being able to read and respond to questions in English, Mandarin, Cantonese, Japanese, or Korean.
- Age ≥ 18 years
- Having a cancer diagnosis
- Likely self-identifying as a Chinese, Japanese, or Korean American/immigrant
- Being able to read and respond to questions in either English, Mandarin, Japanese, Korean, or Chinese dialects, such as Cantonese, Shanghai, Taishanese, or Taiwanese.
- Age ≥ 18 years
- Being able to read and respond to questions in either English, Mandarin, Japanese, Korean, or Chinese dialects, such as Cantonese, Shanghai, Taishanese, or Taiwanese
- Having a family member who is likely to self-identify as a Chinese, Japanese, or Korean American/immigrant and has been diagnosed with cancer
Exclusion Criteria1
- Having cognitive impairment per the Short Portable Mental Status Questionnaire with more than three errors
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The Culturally Tailored Digital Resilience-Building materials include an introduction to advance care planning and resilience skills that specifically address cultural beliefs and barriers.
Semi-structured interviews with religious leaders who provide spiritual care to Asian Americans/immigrants.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06035549